Alexis Peyroles has more than 20 years of international management and financial control experience, having served in multiple related positions. Since 2013, Alexis Peyroles has been involved in OSE Pharma, both as CFO and in charge of Business Development. From May 2016 to April 2018, he served as COO of OSE Immunotherapeutics, in charge of Finance, Business Development and Operations. Alexis Peyroles graduated from EDHEC Business School and holds an Executive MBA from Imperial College in London.